ArticleCureus2025
A Case Report of Lupus Cerebritis in a Female With Preceding Kikuchi-Fujimoto Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic Challenges and Scientific Management of Suspected Recurrent Kikuchi-Fujimoto Disease: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rare, benign, self-limiting illness known as Kikuchi-Fujimoto disease (KFD) is characterized by fever and lymphadenopathy in young females. Systemic lupus erythematosus (SLE), on the other hand, is a fairly prevalent autoimmune disease. Kikuchi disease is sometimes associated with SLE, with which it may coexist. To validate the diagnosis, the presence of necrotizing lymphadenitis is considered to be of significance. A positive anti-nuclear antibody (ANA) suggests a potential association with SLE or a relapse of the underlying condition. To avoid incorrect diagnosis and ineffective therapy, this clinical presentation requires a comprehensive evaluation. Steroids and immunological therapy are used to treat Kikuchi illness, which is a persistent and recurrent condition that usually requires supportive care. Early diagnosis of ominous disorders requires long-term surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.